| ABC | ATP-binding cassette |
| ABCB1 | ATP-binding cassette B1 Transporter |
| ABCC1 | ATP-binding cassette C1 Transporter |
| ABCC2 | ATP-binding cassette C2 transporter |
| ABCC5 | ATP-binding cassette C5 Transporter |
| ABCG2 | ATP-binding cassette G2 Transporter (Junior blood group) |
| ADC | Antibody-drug conjugate |
| Akt | Protein kinase B |
| ALK | Anaplastic Lymphoma Kinase |
| ALL | Acute lymphoblastic leukemia |
| ATM | Ataxia telangiectasia mutated |
| BAX | BCL2 associated X |
| BCL-2 | B-cell lymphoma 2 |
| BCL-XL | B-cell lymphoma-extra large |
| BCRP | Breast cancer resistance protein |
| BCSCs | Breast cancer stem cells |
| CSCs | Cancer stem cells |
| ctDNA | circulating tumor DNA |
| CTRP | Clinical trials reporting program |
| Cul3 | Cullin3 |
| CYP | Cytochrome P450 |
| DDR | DNA damage response |
| DKK1 | Dickkopf-1 |
| EMT | Epithelial-mesenchymal transition |
| EMT-TFs | EMT-inducing transcriptional factors |
| FA | Folic acid |
| FOXC2 | Forkhead box C2 |
| FOXM1 | Forkhead box M1 |
| GDSC | Genomics of drug sensitivity in cancer |
| GST | Glutathione S-transferase |
| HCC | Hepatocellular carcinoma cells |
| ICAM-1 | Intercellular adhesion molecule 1 |
| KEAP1 | Kelch-like ECH-associated protein 1 |
| LFA-1 | Leukocyte function-associated antigen 1 |
| LncRNA | Long non-coding rnas |
| LRP | Lung resistance-related protein |
| LSCC | Lung squamous cell carcinoma |
| LUAD | Lung adenocarcinoma |
| MAPK | Mitogen-activated protein kinase |
| MDR | Multidrug resistance |
| MGMT | Methylguanine DNA methyltransferase |
| MRE11 | Double strand break protein |
| MRP1 | Multidrug resistance-associated protein 1 |
| MRP2 | Multidrug resistance protein 2 |
| NFE2L2 | Nuclear factor (erythroid-derived 2)-like 2 |
| NFkB | Nuclear factor-κB |
| NSCLC | Non-small cell lung cancer |
| OS | Overall survival |
| PARP | Poly(ADP-Ribose) polymerase 1 |
| PBM | Planetary ball milled |
| PET | Positron emission tomography |
| P-gp | P-glycoprotein |
| PI3K | Phosphoinositide 3-kinase |
| PSA | Prostate-specific antigen |
| RFC | Reduced folate carrier |
| TGF-β | Transforming growth factor β |
| TKI | Tyrosine kinase inhibitor |
| TME | Tumor microenvironment |
| Topo-II | Topoisomerase II |
| TTF | Time to treatment failure |
| Tβ4 | Thymosin β4 |
| UCA1 | Urothelial cancer associated 1 |
| UNRES | Unexpectedly resistant |
| VCAM | vascular adhesion molecule |
| VEGFR | Vascular endothelial growth factor receptor |
| VLA-4 | Very late antigen 4 |
| Wnt6 | Wnt family member 6 |
| ZEB1 | Zinc finger e-box binding homeobox 1 |